This report studies the global market size of Antipsychotic Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antipsychotic Drugs in these regions.
Download FREE Sample of this Report @ https://www.24marketreports.com/report-sample/global-antipsychotic-drugs-2025-453
This research report categorizes the global Antipsychotic Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.
Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder.During 2016, the second-generation antipsychotic drugs segment dominated the antipsychotic drugs market with the highest market shares. These drugs are preferred over first-generation antipsychotic drugs because they involve lesser side effects and are highly efficient in the treatment of various mental disorders. The adoption of these drugs is high because they reduce EPSE, controls symptoms, and maintains the normal levels of prolactin. This segment yields a high prescription value that in turn, will drive growth in the segment during the forecasted period.
In 2017, the global Antipsychotic Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Antipsychotic Drugs market based on company, product type, application and key regions.
The various contributors involved in the value chain of Antipsychotic Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Antipsychotic Drugs include
- AstraZeneca
- Eli Lilly
- GlaxoSmithKline
- Johnson & Johnson
- Actavis Generics
- Alkermes
- Bristol-Myers Squibb
Market Size Split by Type
- First Antipsychotic Drugs
- Second Antipsychotic Drugs
- Third Antipsychotic Drugs
Market Size Split by Application
- Schizophrenia
- Bipolar Disorder
- Unipolar Depression
- Dementia
- Others
Market size split by Region
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Singapore
- Malaysia
- Philippines
- Thailand
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Central & South America
- Brazil
- Rest of Central & South America
- Middle East & Africa
- GCC Countries
- Turkey
- Egypt
- South Africa
The study objectives of this report are:
- To study and analyze the global Antipsychotic Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
- To understand the structure of Antipsychotic Drugs market by identifying its various subsegments.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- Focuses on the key global Antipsychotic Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Antipsychotic Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
- To project the value and volume of Antipsychotic Drugs submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Antipsychotic Drugs are as follows:
- History Year: 2013-2017
- Base Year: 2017
- Estimated Year: 2018
- Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antipsychotic Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of content
1 Study Coverage
1.1 Antipsychotic Drugs Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Antipsychotic Drugs Market Size Growth Rate by Type
1.4.2 First Antipsychotic Drugs
1.4.3 Second Antipsychotic Drugs
1.4.4 Third Antipsychotic Drugs
1.5 Market by Application
1.5.1 Global Antipsychotic Drugs Market Size Growth Rate by Application
1.5.2 Schizophrenia
1.5.3 Bipolar Disorder
1.5.4 Unipolar Depression
1.5.5 Dementia
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antipsychotic Drugs Market Size
2.1.1 Global Antipsychotic Drugs Revenue 2016-2025
2.1.2 Global Antipsychotic Drugs Sales 2016-2025
2.2 Antipsychotic Drugs Growth Rate by Regions
2.2.1 Global Antipsychotic Drugs Sales by Regions
2.2.2 Global Antipsychotic Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Antipsychotic Drugs Sales by Manufacturers
3.1.1 Antipsychotic Drugs Sales by Manufacturers
3.1.2 Antipsychotic Drugs Sales Market Share by Manufacturers
3.1.3 Global Antipsychotic Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Antipsychotic Drugs Revenue by Manufacturers
3.2.1 Antipsychotic Drugs Revenue by Manufacturers (2016-2018)
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Fax: (+1) 212 634 4885
Email: help@24marketreports.com
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports